We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Expert Opinion / Commentary · November 16, 2016

2016 Top Stories in Neurology: Parkinson's Disease

Written by
Mark Hallett MD


Additional Info

  1. Fernandez-Arcos A, Iranzo A, Serradell M, et al. The clinical phenotype of idiopathic rapid eye movement sleep behavior disorder at presentation: a study in 203 consecutive patients. Sleep. 2016;39(1):121-132.
  2. Podgorny PJ, Suchowersky O, Romanchuk KG, Feasby TE. Evidence for small fiber neuropathy in early Parkinson's disease. Parkinsonism Relat Disord. 2016;28:94-99.
  3. Stokholm MG, Danielsen EH, Hamilton-Dutoit SJ, Borghammer P. Pathological alpha-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients. Ann Neurol. 2016;79(6):940-949.
  4. Vilas D, Iranzo A, Tolosa E, et al. Assessment of alpha-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study. Lancet Neurol. 2016;15(7):708-178.
  5. Adler CH, Dugger BN, Hentz JG, et al. Peripheral synucleinopathy in early Parkinson's disease: submandibular gland needle biopsy findings. Mov Disord. 2016;31(2):250-256.
  6. Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Exploring the association between rosacea and Parkinson disease: a danish nationwide cohort study. JAMA Neurol. 2016;73(5):529-534.
  7. Mirelman A, Bernad-Elazari H, Thaler A, et al. Arm swing as a potential new prodromal marker of Parkinson's disease. Mov Disord. 2016;31(10):1527-1534.
  8. Noyce AJ, Lees AJ, Schrag AE. The prediagnostic phase of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2016;87(8):871-878.
  9. Elbaz A. Prodromal symptoms of Parkinson's disease: implications for epidemiological studies of disease etiology. Rev Neurol (Paris). 2016;172(8-9):503-511.
  10. Berg D, Postuma RB, Adler CH, et al. MDS research criteria for prodromal Parkinson's disease. Mov Disord. 2015;30(12):1600-1611.

Disclosure statements are available on the authors' profiles:

Further Reading